01:17 PM EST - MYM Nutraceuticals : has entered into an exclusive agreement to acquire a 51-per-cent interest in Sublime Culture Inc., a company possessing an application -- currently in its inspection stage (stage 4 of five) -- to become a licensed producer under Health Canada's access to cannabis for medical purposes regulations. Pursuant to the agreement, MYM will issue one million common shares to the principals of Sublime and finance $1.8-million for the completion and initial operation of a licensed production facility. Once operation of the facility has commenced, the company has agreed to issue options to purchase 200,000 MYM shares to the shareholders of Sublime, as well as an additional 200,000 MYM options every year thereafter that the facility remains in operation and MYM is materially involved in its operation and production. MYM Nutraceuticals
shares MYM:CNX are trading up 0.01 at $0.13.
